burrill & company exclusive focus on life sciences human healthcare rx and dx nutraceuticals wellness agbio industrial enabling technologies venture capital group investing across the entire spectrum of biotechnology over 625 million for investment raising 300 500 blscf iii merchant banking practice strategic partnering including licensing research other collaborations advisory services new formation merger acquisitions spin outs ranging from products to divisions disease area franchises media conferences publications headcount 50 professionals staff location san francisco funds under management millions created hosted industry events publishing 2006 biotech book science indices monthly personalized medicine stem cells quarterly newsletters china india canada m&a website online resource keeping up date information about is go firm insight reports this presentation available download our www burrillandco com so what s happened in these 20 years by way started 10 15 earlier late 60s early 70s it a 35 year old
